What is it about?
An effective and long lasting vaccine would greatly accelerate the control and eventual elimination of malaria. Currently available vaccines are only partially effective,which justifies the continuous search for new vaccine candidates. The antigen termed UB05-09 has been tested and found herein to be a good marker of protective immunity to malaria.We propose that it should be further tested as a potential vaccine candidate.
Featured Image
Why is it important?
The fusion of the antigen UB05-09 from its components UB05 and UB 09 makes it more effective than its components in discriminating between semi immune individuals and those who are frequently sick of malaria.
Perspectives
We plan to carry out more tests to see if the antigen UB05-09 can be developed as a vaccine against malaria.
Prof VINCENT P.K. TITANJI
University of Buea
Read the Original
This page is a summary of: Differential T-cell responses to a chimericPlasmodium falciparumantigen; UB05-09, correlates with acquired immunity to malaria, Parasite Immunology, April 2016, Wiley,
DOI: 10.1111/pim.12318.
You can read the full text:
Contributors
The following have contributed to this page
